Novo Nordisk Q3 2025 Earnings Beat: Wegovy Sales Surge 80% to $4.5 Billion Amid Global Obesity Treatment Boom
Novo Nordisk(NVO) reported a stellar third-quarter 2025 earnings beat on November 5, 2025, with revenue climbing 28% year-over-year to DKK 88.7 billion ($12.8 billion USD), surpassing analyst forecasts of DKK 86.5 billion. The Danish pharmaceutical leader’s performance, propelled by blockbuster […]










